• Date: April 03, 2017

Cemark, one of the projects chosen during the previous edition of the CaixaImpulse programme, has already begun the testing phase of its research.

Endometrial cancer is the fourth most common in women and it affects more than 280,000 people per year. The number of cases per year has gone up by 21% since 2008. This is the reason why the researchers at Vall d’Hebron Hospital have created a standard diagnosis based on the observation of malignant cells in an endometrial biopsy.

As Eva Colas—a member of the Biomedical Research Group in Gynaecology of the Vall d'Hebron Research Institute (VHIR)—explains, the problem is that sometimes, it is not possible to obtain enough cells for the test to be valid. This situation happens in 22% of cases and leads to additional invasive testing. This is why the team wants to make diagnosis possible without performing tedious and invasive rounds of testing.

The greatest problem lies in the diagnosis, as it is a very tedious process which many women have to go through. One of the symptoms that can warn patients and doctors is abnormal vaginal bleeding, although it is a very unspecific sign.

The CaixaImpulse programme has provided consultancy services and funding to the researchers of Cemark. And they have been able to diagnose this cancer using endometrial fluid by performing a simple test based on the presence of two proteins.

Cemark’s work does not end here, as it still has to go through clinical practice, the valuation process and final kit development.  “We have to continue working with the same motivation and desire to innovate together with a great team, as we get closer to the finish line”, concludes Eva Colas. 

More news

May 25, 2017

CataloniaBio and HealthTech Cluster will fuse together into one single entity

The Catalan groups agreed to begin the process of integrating into a single one. This will bring together more than 200 entities with the aim of creating synergies and growing strategically.

May 09, 2017

Apo J-Glyc continues to make breakthroughs in the early diagnosis of myocardial ischaemia

The project will make early detection of events that lead to cardiac emergencies possible, speeding up and improving the diagnosis of the disease and its impact.

May 04, 2017

Greater patent value with the new law of 1 April

The new patent law is more restrictive and brings major developments with respect to the law in force until now. According to experts, this regulation will position Spain on par with the most developed countries.